Alfonso Zambon

11PUBLICATIONS
26CO-AUTHORS
Molecular targetsGlassComposite and hybrid materialsRespiratory diseasesOptical properties of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 19, 2026
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models.

|Jul 02, 2025
Polyphosphate coacervate gels for manufacturing of manganese loaded glass powders and fibres: structural, cytocompatibility and surface bioactivity study.

Chiara Cavazzoli, Roberto Di Pasquale, Zarrin Moghaddam

|Jun 25, 2025
Gelatin/Cerium-Doped Bioactive Glass Composites for Enhancing Cellular Functions of Human Mesenchymal Stem Cells (hBMSCs).

Andrey Iodchik, Gigliola Lusvardi, Alfonso Zambon

|Feb 24, 2025
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia.

Lorenza Destro, Valentina Crippa, Daniela Gabbia

|Feb 13, 2025
Evaluation of the Properties of Bioactive Mesoporous Glasses Doped with Cerium and Loaded with Polyphenols.

Alessia Giordana, Chiara Cavazzoli, Francesca Fraulini

|Jan 30, 2025
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy?

Alfonso Zambon

Pageof 2

Frequent Collaborators

4 joint publications

Gigliola Lusvardi

3 joint publications

Luca Mologni

2 joint publications

Alexandre Orsato

2 joint publications

Francesca Fraulini